Sources: CBC
Pfizer and BioNTech say that their COVID-19 vaccine is 80% effective in young children. 2022-05-23
BioNTech CEO Uğur Şahin and Pfizer CEO Albert Bourla both say that their vaccine is likely to be effective against severe disease resulting from the Omicron variant. 2021-11-30
The European Commission signs a new deal with Pfizer and BioNTech to purchase 900 million doses of its vaccine with an additional option to purchase another 900 million doses for delivery from 2021 to 2023 which they intend to use as booster shots against the illness and to allow for the vaccination of children and teenagers. 2021-05-8
The first 30,000 doses of the Pfizer-BioNTech vaccine are sent from Spain to Andorra after both governments reached an agreement earlier today. 2021-01-19
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
The government signs a deal with Pfizer and BioNTech to buy an additional 12.2 million doses of the tozinameran vaccine. 2021-01-11
Qatar begins administering the Pfizer-BioNTech vaccine tozinameran to its citizens at designated health centers in the country. Those aged over 70, adults with chronic health conditions and healthcare personnel are to be prioritised for the vaccine. 2020-12-23
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7
Bahrain grants emergency use authorization for the COVID-19 vaccine made by Pfizer and BioNTech, becoming the second country after the United Kingdom to approve the vaccine. 2020-12-4
The United Kingdom approves the BNT162b2 vaccine made by Pfizer and BioNTech for widespread use, becoming the first country in the world to approve the vaccine. The government states that the vaccine will be rolled out early next week. 2020-12-2